+7 (495) 505-52-05

" "





2013-06-04 20:44:47

. . . , . 250 . 2 . (34), , 500 . 2 . - ? ....
2013-05-15 20:22:14

10. 20. ? ...
2013-05-05 12:39:07

! 4 , , - , ?...
2013-04-24 10:50:26

! : , . : + + . , , , . 2- . - , . . . 3 ......
2013-04-18 21:36:56

! . 50 . . : - , - , . . . - . - , , . , . . ......

,
:

. ""

HEADING_TITLE_2
?
??
1 5 N20 /
- 20 N20
1 5 N20 /
- 5 N20
N100
10 N20
N60
10 N60 -
0 3 N20 -
2 5 N20
300 N10
2 5 N60 -
300 N10 1/10
20 N20
0 1% 10
20 N60
25
5 N20
75
5 N60
N20 /
-H 12 5+10 N20
- N20 /
-H 12 5+10 N60
- N24
-H 20 N20
/ 46
- 25+10 N20
30
N50 Biologische Heilmittel Heel GmbH
100 N60
0 275 N30
25 N60
- 50
50 N60
50 N50 Baxter Oncology
10+5 N30
55 318 N6 / - /
5+5 N30
200 N60 Servier Laboratoires
75 N28
2 5+10 N153
200 N12
2 5+20 N15+30
50 N30
N20 Torrent Pharmaceuticals Ltd
25
N40 Torrent Pharmaceuticals Ltd
5 N28
- N20
-306 100
300 N30
-801 25
N50 - +
10 N20
- N100 - +
20 N20
20 Deutsche Homoopathie Union
10 N28 -
100 N20 /
5+10+10 N30
250 N10
10+20 N30
250 N10 /
5+10 N30
250 N20 /
0 45 N60 AAPO-SPA
250 N30
1% 10 Dr Reddy s Laboratories Ltd
250 N30
1% 10 - / Globopharm pharmazeutische Productions u
250 N50
1% 15 / Merck KGaA & Co
300 N20
1% 20 - / Globopharm pharmazeutische Productions u
225
1% 30 / Merck KGaA & Co
225
1% 30 - / Globopharm pharmazeutische Productions u
100 N30
1% 10 /
200 N16
125+31 25/5 25 / /
200/5 90
250+125 N15
200 / Merck KGaA & Co Werk Spittal
250+62 5/5 25 / /
0 5 N60
875+125 N14
0 1% 15
100 N30
0 1% 60
200 N16
/ 250
200 N30
2/ 150
100 N3 Farmea
80 N30
100 N6 Farmea
30
N10
- 20 -
N20
10% 2 /
1 5 N28
(-) 30
3 N28
N20 /
4 6/24 N30 LTS Lohmann Therapie-Systems AG
2/ 150 Servier Laboratoires
9 5/24 N30 Lomapharm Rudolf Lohmann
2/ 250 Les Laboratoires Servier Industrie
/ 100
80 N30 Servier Laboratoires
250
2/ 150 Sandoz Ilac Sanayi ve Ticaret A S
10 N10 / - /
80 N15 Sandoz Ilac Sanayi ve Ticaret A S
10 N20 / - /
80 N20 Sandoz Ilac Sanayi ve Ticaret A S
5 N6 / - / /
80 N30 Sandoz Ilac Sanayi ve Ticaret A S
23 5
10000/ 10
512 3
250 N20
511 N3
5 N10 -
12 N24 Young Chemical Co Ltd
60 -
10+160 N28
10000 N20 &
5+160 N28
10000 N50 &
5+80 N28
25000 N20 &
80 N30
25000 N50 &
N30
200 N14
N60
200 N28
N30
N1
N100 Rottendorf Pharma GmbH
120 N112 -
N30 Rottendorf Pharma GmbH
120 N40 -
2 N20 /
2 5 N30
N50
5 N30
500 N10 Ranbaxy
20 - / Pharma Wernigerode GmbH
1% 15 /
N30
1% 30 /
- 600 N30 Pharma Wernigerode GmbH
5 N10
25 N30
2 5 N60 Bristol-Myers Squibb
50 N30
5 N60 Bristol-Myers Squibb
40 N25 -
10 N28 -
40 N50 -
10 N56 -
L 40/ 30 -
6 50 GABA Interntional
100/1 30 / -
0 1% 15 / -
100/1 50 / -
0 1% 15 / -
125 N14 HERMES Pharma Ges m b H
0 1% 30 - /
250/5 5 N5 - / -
N30
300 N30
0 5
300 N90
N6
0 3 N30
30% 100 - -
0 3 N90
30% 50 - -
N30 Nabros Pharma
1 2
N50 Nabros Pharma
25
0 6/ 80
20 N14
10 N50
20 N28
4 N50
40 N28
50 N50
30 Recipharm Karlskoga AB
0 05% 60
5 N5 Recipharm Karlskoga AB
3 N60
5 N5 Recipharm Karlskoga AB 1/5
100 N100 Merck KGaA
- 1% 5 N1
125 N100 Merck KGaA
10/ 1 N10 - /
150 N100 Merck KGaA
75
25 N100 Merck KGaA
75
50 N100 Merck KGaA
50
75 N100 Merck KGaA
/ 200
150 N30
/ 200
2 4% 10 N10 - / /
/ 200
2 4% 5 N10 - / /
10 N20
20 Biologische Heilmittel Heel GmbH
10 N20
30 /
10 N28
/ 82
20 N20
150 N12 /
20 N28
300 N12 /
5 N20
30/ 90 / Bristol-Myers Squibb
5 N20
500 N16 Bristol-Myers Squibb
5 N28